Verici Dx Plc (VRCI)

London
22.75
0.00(0.00%)
  • Volume:
    62,714
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    22.75 - 22.75

VRCI Overview

Prev. Close
22.75
Day's Range
22.75-22.75
Revenue
-
Open
22.75
52 wk Range
14-76.48
EPS
-0.05
Volume
62,714
Market Cap
44.95M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
187,637
P/E Ratio
-4.66
Beta
0.601
1-Year Change
-70.37%
Shares Outstanding
197,601,737
Next Earnings Date
-
What is your sentiment on Verici?
or
Market is currently closed. Voting is open during market hours.

Verici Dx Plc Company Profile

Verici Dx Plc Company Profile

Employees
10

Verici Dx plc, an immuno-diagnostics development company, focuses on the kidney transplantation market. The company develops prognostic and diagnostic tests for kidney transplant patients. Its in-development tests include Clarava, a pre-transplant prognosis test for the risk of early acute rejection; Tuteva, a post-transplant test that focuses on acute cellular rejection; and Protega, a liquid biopsy that aims to predict the risk of fibrosis and long-term graft failure. The company was incorporated in 2020 and is based in Penarth, the United Kingdom.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuySellStrong Sell
Technical IndicatorsStrong BuyStrong BuyStrong BuyStrong BuyStrong Sell
SummaryStrong BuyStrong BuyStrong BuyNeutralStrong Sell